Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02184117 · ClinicalTrials.gov registry record
CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 763
- Enrollment target
NCT02184117: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT02184117 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 763 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02184117 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 763 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the diagnostic performances of iodine contrast medium and resting conditions to predict fractional flow reserve (FFR). Reference FFR will be measured using standard adenosine. We hypothesize that contrast FFR will offer superior diagnostic agreement compared to resting conditions.
Primary Outcome
To quantify any improvement in binary agreement from resting conditions to contrast medium injection, using adenosine-derived FFR≤0.8 as the reference standard.
Interventions
- DRUG Adenosine
- DRUG Contrast Media
- DRUG Resting conditions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 763 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-05 |
What the finished NCT02184117 record still lists
NCT02184117 is an observational study that tracks outcomes without assigning an intervention. The registered 763 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Adenosine is the first listed.
NCT02184117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02184117 about?
NCT02184117 is a clinical study titled "CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)". The purpose of this study is to determine the diagnostic performances of iodine contrast medium and resting conditions to predict fractional flow reserve (FFR). Reference FFR will be measured using standard adenosine. We hypothesize that contrast FFR will offer superior diagnostic agreement compared...
What is the current status of trial NCT02184117?
This trial is currently completed. The enrollment target is 763 participants. The study started on 2014-07. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02184117?
The interventions under investigation include: Adenosine (DRUG), Contrast Media (DRUG), Resting conditions (DRUG).
Who is sponsoring clinical trial NCT02184117?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578665 · 764 participants · NA
Human-like Robotic Controllers for Enhanced Motor Learning
- NCT05579366 · 764 participants · Phase 1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- NCT06419374 · 762 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- NCT03789552 · 765 participants · Phase 3
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia